Skip to content

Application and mechanism of Qingjin Huatan Decoction in the treatment of stroke-related pneumonia

Application and mechanism of Qingjin Huatan Decoction in the treatment of stroke-related pneumonia

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078758
Enrollment
Unknown
Registered
2023-12-18
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke-Associated Pneumonia

Interventions

Control Group:The control group received basic treatment and routine rehabilitation training
Intervention Group:The intervention group was treated with Qingjin Huatan Decoction on the basis of control group.

Sponsors

Jinhu County People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for acute ischemic stroke and cerebral hemorrhage in the Chinese Guidelines for the Diagnosis and Treatment of acute Ischemic Stroke (2018) or the Chinese Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage (2019) (2) It meets the diagnostic criteria for stroke-related pneumonia in the Chinese Expert Consensus on the Diagnosis and Treatment of Stroke-related Pneumonia (2019 Updated version) (3) It meets the relevant standards in the "Guidelines for the Diagnosis and Treatment of Common Diseases in TCM Internal Medicine - Apoplexy" and the "Guidelines for the Diagnosis and Treatment of Common Diseases in TCM Internal Medicine - Part of TCM Diseases and Syndromes" (4) Age =18 years old, first onset of disease, voluntary participation in the project and signed informed consent.

Exclusion criteria

Exclusion criteria: Patients with brain trauma, uncontrolled infection or high fever, respiratory failure, extreme weakness, severe hypertension, severe heart dysfunction and other serious underlying diseases.

Design outcomes

Primary

MeasureTime frame
Pulmonary infection;

Secondary

MeasureTime frame
activity of daily living;Inflammatory factor levels;Immune function;

Countries

China

Contacts

Public ContactJin Xu

Jinhu County People's Hospital

675704818@qq.com+86 198 5170 0109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026